Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 17, 2024 - Issue
Submit an article Journal homepage
156
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES

Abrocitinib as a Novel Treatment for Multiple Skin Disorders: 3 Case Reports and a Scoping Review

Pingjiao Chen1 Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People’s Republic of China
,
Jingyao Liang2 Institute of Dermatology, Guangzhou Medical University, Guangzhou, 510095, People’s Republic of China;3 Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, People’s Republic of China
,
Changxing Li1 Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People’s Republic of China
,
Qian Li2 Institute of Dermatology, Guangzhou Medical University, Guangzhou, 510095, People’s Republic of China;3 Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, People’s Republic of China
,
Wenyan Liu2 Institute of Dermatology, Guangzhou Medical University, Guangzhou, 510095, People’s Republic of China;3 Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, People’s Republic of China
,
Junhui Zhu2 Institute of Dermatology, Guangzhou Medical University, Guangzhou, 510095, People’s Republic of China;3 Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, People’s Republic of China
,
Weifeng Chen2 Institute of Dermatology, Guangzhou Medical University, Guangzhou, 510095, People’s Republic of China;3 Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, People’s Republic of China
&
Xibao Zhang2 Institute of Dermatology, Guangzhou Medical University, Guangzhou, 510095, People’s Republic of China;3 Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 35-40 | Received 24 Oct 2023, Accepted 28 Nov 2023, Published online: 06 Jan 2024

References

  • Bai J, Su W, Fang H, Qiao J. Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: a pilot study in two cases. Int J Dermatol. 2023;62(9):e480–e483. doi:10.1111/ijd.16698
  • Baltazar D, Shinamoto SR, Hamann CP, Hamann D, Hamann CR. Occupational airborne allergic contact dermatitis to invasive Compositae species treated with abrocitinib: a case report. Contact Dermatitis. 2022;87(6):542–544. doi:10.1111/cod.14204
  • Zhao J, Liu L. A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib. JAAD Case Rep. 2022;22:99–100. doi:10.1016/j.jdcr.2022.02.027
  • Bao C, Xu Q, Xiao Z, et al. Abrocitinib as a novel treatment for lichen sclerosus. Br J Dermatol. 2023;189(1):136–138. doi:10.1093/bjd/ljad129
  • Huang J, Liu O. Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib. J Cosmet Dermatol. 2023. doi:10.1111/jocd.15896
  • Zhang J, Zuo YG. Successful treatment of alopecia universalis with abrocitinib: a case report. J DermatolTreat. 2023;34(1):2242706. doi:10.1080/09546634.2023.2242706
  • Bennett M, Moussa A, Sinclair R. Successful treatment of chronic severe alopecia areata with abrocitinib. Australas J Dermatol. 2022;63(2):274–276. doi:10.1111/ajd.13836
  • Xia J, Jiang G. A report of eruptive pruritic papular porokeratosis treated with abrocitinib. Clin Cosmet Invest Dermatol. 2023;16:2223–2227. doi:10.2147/CCID.S424310
  • Li Y, Jiang Y, Sun J. Improvement of Hailey-Hailey disease with abrocitinib. Clin Exp Dermatol. 2023;48(5):532–533. doi:10.1093/ced/llad023
  • Arnet L, Erfurt-Berge C. Effect of abrocitinib in a patient with extensive necrobiosis lipoidica. J Eur Acad Dermatol Venereol. 2023;37(10):e1208–e1210. doi:10.1111/jdv.19189
  • Zheng CC, Chen XX, Zou RT, Cai GY, Chen RY. Treatment of Netherton syndrome with abrocitinib. JAMA Dermatol. 2023;159(7):791–793. doi:10.1001/jamadermatol.2023.0561
  • Solimani F, Mesas-Fernandez A, Dilling A, et al. The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus. J Eur Acad Dermatol Venereol. 2023. doi:10.1111/jdv.19069
  • Teng Y, Tang H, Yu Y, Fan Y, Tao X, Xu D. Successful treatment of atopic dermatitis with a predominant nipple involvement by abrocitinib during COVID-19 pandemic: a case report. J Asthma Allergy. 2023;16:789–792. doi:10.2147/JAA.S422836
  • Vander Does A, Yosipovitch G. Failure of dupilimab with severe prurigo nodularis that responded well to abrocitinib. Dermatitis. 2023. doi:10.1089/derm.2022.0065
  • Shi VY, Bhutani T, Fonacier L, et al. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND). J Am Acad Dermatol. 2022;87(2):351–358. doi:10.1016/j.jaad.2022.04.009

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.